Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitors.
about
Key tumor suppressor genes inactivated by "greater promoter" methylation and somatic mutations in head and neck cancer.Genetic neuropathology of obsessive psychiatric syndromes.Combining the pan-aurora kinase inhibitor AMG 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancerAugmenting antitumor immune responses with epigenetic modifying agents.Microarray gene expression profiling reveals potential mechanisms of tumor suppression by the class I HDAC-selective benzoylhydrazide inhibitors.Alterations in cellular metabolome after pharmacological inhibition of Notch in glioblastoma cells.Inhibitors of histone deacetylase 1 reverse the immune evasion phenotype to enhance T-cell mediated lysis of prostate and breast carcinoma cells.Human Th17 Cells Lack HIV-Inhibitory RNases and Are Highly Permissive to Productive HIV Infection.Expression of HIV-1 matrix protein p17 and association with B-cell lymphoma in HIV-1 transgenic mice.Histone Deacetylase Inhibitors as Anticancer Drugs.Integration of Hedgehog and mutant FLT3 signaling in myeloid leukemia.HES6 promotes prostate cancer aggressiveness independently of Notch signalling.MicroRNA expression profiling of Xp11 renal cell carcinoma.Epigenetic priming of both tumor and NK cells augments antibody-dependent cellular cytotoxicity elicited by the anti-PD-L1 antibody avelumab against multiple carcinoma cell types
P2860
Q34084254-05226B73-7A14-400C-9415-64621A949D36Q34370439-E07EF6D0-7354-406E-ABA0-810D201696EEQ34998552-6C0842B0-5B73-46F4-8394-8FFC1B87EE5DQ35048054-EC0136F5-FFC5-43FD-93EC-BC9DF0AE7E95Q35884595-555BE037-E339-411C-AB81-1ED71FF81177Q36633528-70709053-BDCC-438F-8146-9D98B8FFD03BQ36946516-7387171A-361D-4A87-9A47-71D048BF5C73Q37182674-FDCB1BF1-93F0-4FF0-86DC-8AB56E1A9033Q37469500-DC35C24F-32E8-4BA9-9DC8-441E870A4CC2Q38696932-8A591EAE-1E80-423A-A74F-D02AD730509BQ38865256-D3F43759-BFCA-44C8-BEB3-11B1F188D8ACQ38888488-F26858B1-5D92-42F5-BEA5-E83E8C9CE402Q50726690-48518C9B-1814-43DA-B4B4-8DF3722D2F09Q58130496-00989325-00D3-4DBD-9126-AB766BD7F70B
P2860
Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Analysis of the genomic respon ...... istone deacetylase inhibitors.
@en
Analysis of the genomic respon ...... istone deacetylase inhibitors.
@nl
type
label
Analysis of the genomic respon ...... istone deacetylase inhibitors.
@en
Analysis of the genomic respon ...... istone deacetylase inhibitors.
@nl
prefLabel
Analysis of the genomic respon ...... istone deacetylase inhibitors.
@en
Analysis of the genomic respon ...... istone deacetylase inhibitors.
@nl
P2093
P2860
P356
P1433
P1476
Analysis of the genomic respon ...... histone deacetylase inhibitors
@en
P2093
Anuj Gupta
Elsken van der Wall
Henk M W Verheul
Judith J M Jans
Madeleine S Q Kortenhorst
Michael A Carducci
Michel D Wissing
Paul J Van Diest
Petra Van der Groep
Ronald Rodríguez
P2860
P304
P356
10.4161/EPI.25574
P577
2013-07-19T00:00:00Z